Cargando…

The future of minimally invasive liver resection for hepatocellular carcinoma BCLC stage 0–A

Detalles Bibliográficos
Autores principales:	Lippert, Trenton, Lim-Dy, Allyson, Sucandy, Iswanto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432291/ https://www.ncbi.nlm.nih.gov/pubmed/37600996 http://dx.doi.org/10.21037/hbsn-23-295

Ejemplares similares

Changes in Performance of More Than 1000 Minimally Invasive Liver Resections
por: Swaid, Forat, et al.
Publicado: (2020)

Impact of Minimally Invasive/Bariatric Surgery Fellowship on Perioperative Complications and Outcomes in the First Year of Practice
por: Sucandy, Iswanto, et al.
Publicado: (2013)

Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System
por: Wee, Ian J Y, et al.
Publicado: (2022)

Hepatic Artery Pseudoaneurysm after Surgical Treatment for Pancreatic Cancer: Minimally Invasive Angiographic Techniques as the Preferred Treatment
por: Iswanto, Sucandy, et al.
Publicado: (2014)

A Nomogram Predicting Microvascular Invasion Risk in BCLC 0/A Hepatocellular Carcinoma after Curative Resection
por: Gao, Shuai-Xiang, et al.
Publicado: (2019)

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
por: Kim, Jun Young, et al.
Publicado: (2016)

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
por: Yang, Shih-Yu, et al.
Publicado: (2021)

Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B
por: Huang, Cheng, et al.
Publicado: (2017)

Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients
por: Zhaohui, Zhang, et al.
Publicado: (2019)

Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
por: Zhong, Jian-Hong, et al.
Publicado: (2013)

Liver resection for hepatocellular carcinoma beyond the BCLC: are multinodular disease, portal hypertension, and portal system invasion real contraindications?
por: Barros, Andrea Zaidan de Almeida, et al.
Publicado: (2022)

Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification
por: Kamiyama, Toshiya, et al.
Publicado: (2017)

Correction: Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
por: Zhong, Jian-Hong, et al.
Publicado: (2014)

The priority of liver resection compared with transarterial chemoembolization in hepatocellular carcinoma at BCLC B1 stage: A single-center experience
por: Yi, Peng-Sheng, et al.
Publicado: (2022)

The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A
por: Zuo, Duo, et al.
Publicado: (2021)

The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: basing on competing risk model
por: Yan, Huiwen, et al.
Publicado: (2022)

Postoperative mesenteric venous thrombosis: Potential complication related to minimal access surgery in a patient with undiagnosed hypercoagulability
por: Sucandy, Iswanto, et al.
Publicado: (2010)

TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma
por: Lima, Henrique A., et al.
Publicado: (2022)

Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System
por: Kikuchi, Luciana, et al.
Publicado: (2016)

Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage
por: Kikuchi, Luciana, et al.
Publicado: (2017)

Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
por: Liu, Kai-Cai, et al.
Publicado: (2020)

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022)

Laparoscopic assisted central pancreatectomy with pancreaticogastrostomy reconstruction - An alternative surgical technique for central pancreatic mass resection
por: Sucandy, Iswanto, et al.
Publicado: (2010)

Liver resection is always a good choice for hepatocellular carcinoma (HCC) patients regardless of Barcelona Clinic Liver Cancer (BCLC) stage: the therapeutic hierarchy
por: Guarino, Maria, et al.
Publicado: (2020)

Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy
por: Huang, Pao-Yuan, et al.
Publicado: (2019)

An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma
por: He, Cheng, et al.
Publicado: (2022)

Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection
por: Li, Chuan, et al.
Publicado: (2018)

Minimally Invasive versus Open Liver Resection for Stage I/II Hepatocellular Carcinoma
por: Birgin, Emrullah, et al.
Publicado: (2021)

Impact of gender as a prognostic factor in HBV-related Hepatocellular Carcinoma: the survival strength of female patients in BCLC stage 0-B
por: Yu, Lihua, et al.
Publicado: (2019)

Past, Present, and Future of Minimally Invasive Abdominal Surgery
por: Antoniou, Stavros A., et al.
Publicado: (2015)

Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center
por: Kim, Sung Eun, et al.
Publicado: (2011)

The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
por: Liu, Shun, et al.
Publicado: (2021)

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage
por: Ninomiya, Masashi, et al.
Publicado: (2023)

A novel use of endoscopic cutter: Endoscopic retrieval of a retained nasogastric tube following a robotically assisted laparoscopic biliopancreatic diversion with duodenal switch
por: Sucandy, Iswanto, et al.
Publicado: (2011)

Comparison of Long-Term Survival of Patients with Solitary Large Hepatocellular Carcinoma of BCLC Stage A after Liver Resection or Transarterial Chemoembolization: A Propensity Score Analysis
por: Zhu, Shao-Liang, et al.
Publicado: (2014)

Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
por: Chen, Shiguang, et al.
Publicado: (2018)

Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival
por: Jin, Chen, et al.
Publicado: (2017)

Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy
por: Saeki, Issei, et al.
Publicado: (2023)

Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC
por: Zhang, Ze-Qun, et al.
Publicado: (2018)

Commentary: Closing the “gaps,” single-stage or two-stage minimally invasive hybrid maze?
por: Patel, Vijay S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_29fbsjonfe50gkf4qj3frq0a09